ER2001

· ExoRNA Bioscience

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ER2001, covering 2025-12-19 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Tolerability Study With ER2001 Intravenous Injection Repetitive Treatment in Adults With Early Manifest Huntington's Disease. [EARLY_Phase 1]

See pricing